MielgoLab

..identifying new combinatorial treatments for cancer

Mielgo Lab Research Focus

Tumours are not only made of tumour cells. Instead, tumours, especially solid tumours, such as pancreatic and breast cancer, are surrounded by non-cancerous cells, also called stromal cells, that form what is known as the tumour microenvironment. Stromal cells can have opposite functions, and either inhibit or support tumour progression. However, the mechanisms by which stromal cells support cancer progression are not completely understood.

Our research focuses on understanding the complex interactions between tumour cells and stromal cells in order to identify new combination treatments targeting both the tumour cells and the tumour supporting functions of the tumour microenvironment.

  • Tumour Microenvironment
  • Macrophages
  • Fibroblasts
  • Combination and targeted therapies
  • Cell Survival
  • Cell Proliferation
  • Cell migration/metastasis
  • Drug resistance
View a short video, introduced by Dr Ainhoa Mielgo, describing the research carried out in her laboratory.

play-video

Contact Details

Dept of Molecular & Clinical Cancer Medicine, Liverpool University, 1st Floor Sherrington Building, Ashton Street, Liverpool, L69 3GE

: +44 (0)151 7949555

Our Goals

Our Vision

We envision a future where anti-cancer treatments are effective, targeted, personalised and affordable.

Research

Understanding the impact of the tumour microenvironment in cancer progression, and finding more effective and targeted combination treatments for cancer.

Our Mission

Our mission is to serve the society through scientific research and teaching.

Teaching & Inspiring

We are a research teaching team and our aim is to train and inspire the next generation of cancer researchers.

Investigating the Tumour Microenvironment

The Tumour Microenvironment

The Tumour Microenvironment (for simplification not all stromal cells are represented)

Our overall goal is to find effective combination treatments that target both the cancer cells and the non-malignant surrounding cells (also known as stromal cells) that support the cancer cells.

In order to find more effective therapeutic opportunities for cancer, we first need to understand of how cancer cells and stromal cells interact and communicate with each other. Finding which signalling networks are activated within the tumour microenvironment and identify those that support cancer progression could lead to the development of more effective treatments.

 

 

Frequently Asked Questions

We have a list of common questions about the role of the pancreas, macrophages, fibroblasts etc. If you have any specific questions please let us know.

Cancer Mortality

An estimated 168.1 million years of healthy life are lost due to cancer every year.

Most common Causes of Cancer

The following is a comprehensive list of deaths attributed to cancer (Source Globocan 2012)

  1. Lung cancer (19% of all cancer deaths; 1.6 million people).
  2. Liver cancer (9% of all cancer deaths; 745,000 people).
  3. Stomach cancer (9% of all cancer deaths; 723,000 people).
  4. Colorectal cancer (9% of all cancer deaths; 694,000 people).
  5. Breast cancer (6% of all cancer deaths; 522,000 people).
  6. Cancer of the esophagus (5% of all cancers diagnosed; 400,000 people).
  7. Pancreas cancer (4% of all cancers diagnosed; 330,000 people).

Male and Female Compared

cancer-deaths